剖宫产鞘内吗啡镇痛后经皮二氧化碳监测的前瞻性观察研究
该前瞻性观察研究纳入120例择期剖宫产健康孕妇,采用鞘内吗啡150μg镇痛,用TOSCA监测经皮二氧化碳(TcCO2)至产后24小时。108例完成研究,32%出现持续高碳酸血症事件(TcCO2>50 mmHg持续≥2分钟),基线TcCO2越高事件发生率越高。
要点
- 剖宫产鞘内吗啡150μg后32%产妇出现持续高碳酸血症事件。
- 高碳酸血症事件中位发生在给药后300分钟,中位事件数3次。
- 基线TcCO2>38 mmHg者高碳酸血症事件发生率高达77.4%。
核心结论
- 接受150μg鞘内吗啡剖宫产镇痛产妇中,持续高碳酸血症事件(TcCO2>50 mmHg持续≥2分钟)发生频繁,发生率为32%。
- 发生高碳酸血症事件的产妇基线TcCO2读数更高。
研究设计与样本
- 前瞻性观察研究,招募120例>37周妊娠健康产妇,108例完成研究。
- 脊髓麻醉用药为12 mg高压布比卡因、15 μg芬太尼和150 μg吗啡。
- 使用TOSCA监测仪于麻醉后监护室重新佩戴并连续测量TcCO2至产后24小时。
主要发现
- 35例(32%;99.15%CI 21%-45%)达到主要结局即持续高碳酸血症事件。
- 从鞘内吗啡给药至高碳酸血症事件的中位时间(IQR)为300(124-691)分钟。
- 事件中位数(IQR)为3(1-6)次,最长持续时间中位数(IQR)为25.6(8.4-98.7)分钟。
- 基线TcCO2中位数(IQR)为35(30-40)mmHg,术后中位数(IQR)为40(36-43)mmHg,差值5 mmHg(99.15%CI 2-8 mmHg,P<.001)。
- 基线TcCO2≤31 mmHg者高碳酸血症事件发生率5.4%,32-38 mmHg者为22.5%,>38 mmHg者为77.4%(P<.001)。
关键数值与推荐
- 高碳酸血症事件定义为TcCO2读数>50 mmHg持续≥2分钟。
- 主要结局为产后24小时内持续高碳酸血症事件发生率。
临床怎么用
- 剖宫产鞘内吗啡镇痛后应关注持续高碳酸血症风险,尤其基线TcCO2>38 mmHg者。
- 经皮二氧化碳监测可用于产后呼吸抑制的早期识别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neuraxial morphine is the most commonly used analgesic technique after cesarean delivery. The incidence of respiratory depression is reported to be very low (0%-1.2%) in this patient population as measured by pulse oximetry and respiratory rates. However, hypercapnia may be a more sensitive measure of respiratory depression. In the current study, the incidence of hypercapnia events (transcutaneous CO2 [TcCO2] >50 mm Hg) for ≥2-minute duration was evaluated using the Topological Oscillation Search with Kinematical Analysis monitor in women who received intrathecal morphine for postcesarean delivery analgesia. METHODS: Healthy women (>37 weeks of gestation) scheduled for a cesarean delivery with spinal anesthesia with intrathecal morphine were recruited. Baseline STOP-BANG sleep apnea questionnaire and TcCO2 readings were obtained. Spinal anesthesia was initiated with 12 mg hyperbaric bupivacaine, 15 µg fentanyl, and 150 µg morphine. The Topological Oscillation Search with Kinematical Analysis monitor was reapplied in the postanesthesia care unit and TcCO2 measurements obtained for up to 24 hours. Supplemental opioid administration and adverse respiratory events were recorded. The primary outcome was the incidence of hypercapnia events, defined as a TcCO2 reading >50 mm Hg for ≥2 minutes in the first 24 hours after delivery. RESULTS: Of the 120 women who were recruited, 108 completed the study. Thirty-five women (32%; 99.15% confidence interval, 21%-45%) reached the primary outcome of a sustained hypercapnia event. The median time (interquartile range [IQR]) from intrathecal morphine administration to the hypercapnia event was 300 (124-691) minutes. The median (IQR) number of events was 3 (1-6) and longest duration of an event was 25.6 (8.4-98.7) minutes. Baseline median (IQR) TcCO2 measurements were 35 (30-0) mm Hg and postoperatively, median (IQR) TcCO2 measurements were 40 (36-43) mm Hg, a difference of 5 mm Hg (99.15% confidence interval of the difference 2-8 mm Hg, P < .001). The incidence of hypercapnia events was 5.4% in women with a baseline TcCO2 value ≤31 mm Hg, 22.5% with a baseline TcCO2 between 32 and 38 mm Hg, and 77.4% with a baseline TcCO2 >38 mm Hg (P < .001). CONCLUSIONS: Hypercapnia events (>50 mm Hg for ≥2-minute duration) occurred frequently in women receiving 150 μg intrathecal morphine for postcesarean analgesia. Higher baseline TcCO2 readings were observed in women who had hypercapnia events.
引用
- Bauchat JR, McCarthy R, Fitzgerald P, et al. Transcutaneous Carbon Dioxide Measurements in Women Receiving Intrathecal Morphine for Cesarean Delivery: A Prospective Observational Study. Anesth Analg. 2017. PMID: 28099291. doi:10.1213/ANE.0000000000001751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。